Elevance Health, Inc. $ELV Stock Holdings Lifted by ARGA Investment Management LP

Key Points

• ARGA Investment Management raised its stake in Elevance Health by 4.6% to 277,755 shares (an additional 12,285 shares), holding about 2.7% of ARGA’s portfolio and roughly $97.4 million (~0.12% of the company) after the filing.
• Elevance beat quarterly expectations with EPS $12.58 vs. $10.74 and revenue $49.49B vs. $48.21B; analysts are split (11 Buy, 11 Hold) with a consensus rating of “Moderate Buy” and a $380.42 average price target.
• The company declared a quarterly dividend of $1.72 (annualized $6.88, ~1.9% yield), with an ex-dividend date and record date on June 10 and a payment on June 25.

ARGA Investment Management LP raised its stake in Elevance Health, Inc. (NYSE:ELV - Free Report) by 4.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 277,755 shares of the company's stock after buying an additional 12,285 shares during the period. Elevance Health makes up about 2.7% of ARGA Investment Management LP's investment portfolio, making the stock its 12th largest holding. ARGA Investment Management LP owned approximately 0.12% of Elevance Health worth $97,367,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Physician Wealth Advisors Inc. raised its holdings in Elevance Health by 331.6% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 82 shares of the company's stock worth $26,000 after buying an additional 63 shares during the period. Rossby Financial LCC raised its holdings in Elevance Health by 110.0% during the 3rd quarter. Rossby Financial LCC now owns 84 shares of the company's stock worth $28,000 after buying an additional 44 shares during the period. Activest Wealth Management raised its holdings in Elevance Health by 66.7% during the 3rd quarter. Activest Wealth Management now owns 85 shares of the company's stock worth $27,000 after buying an additional 34 shares during the period. Motco raised its stake in Elevance Health by 334.8% during the 3rd quarter. Motco now owns 100 shares of the company's stock valued at $32,000 after purchasing an additional 77 shares during the period. Finally, ORG Partners LLC raised its stake in Elevance Health by 120.4% during the 4th quarter. ORG Partners LLC now owns 108 shares of the company's stock valued at $38,000 after purchasing an additional 59 shares during the period. Institutional investors and hedge funds own 89.24% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ELV shares. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Elevance Health from $332.00 to $363.00 and gave the company a "hold" rating in a research note on Thursday, April 23rd. Royal Bank Of Canada downgraded shares of Elevance Health from an "outperform" rating to a "sector perform" rating and set a $358.00 target price on the stock. in a research note on Tuesday, February 3rd. UBS Group set a $400.00 target price on shares of Elevance Health in a research note on Thursday, January 29th. Robert W. Baird boosted their target price on shares of Elevance Health from $317.00 to $331.00 and gave the company a "neutral" rating in a research note on Thursday, April 23rd. Finally, Wall Street Zen downgraded Elevance Health from a "buy" rating to a "hold" rating in a report on Sunday, February 8th. Eleven research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $380.42.

Elevance Health Price Performance

Shares of ELV opened at $356.27 on Tuesday. Elevance Health, Inc. has a fifty-two week low of $273.71 and a fifty-two week high of $427.54. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.48 and a quick ratio of 1.48. The company has a market capitalization of $77.37 billion, a price-to-earnings ratio of 15.15, a P/E/G ratio of 2.06 and a beta of 0.49. The business's 50-day moving average is $309.16 and its 200-day moving average is $331.21.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $12.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.74 by $1.84. Elevance Health had a return on equity of 15.58% and a net margin of 2.62%.The business had revenue of $49.49 billion during the quarter, compared to analyst estimates of $48.21 billion. During the same period last year, the company earned $11.97 earnings per share. Elevance Health's quarterly revenue was up 1.5% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 19.850- EPS. Equities research analysts expect that Elevance Health, Inc. will post 26.81 EPS for the current fiscal year.

Elevance Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Wednesday, June 10th will be issued a $1.72 dividend. The ex-dividend date is Wednesday, June 10th. This represents a $6.88 dividend on an annualized basis and a yield of 1.9%. Elevance Health's dividend payout ratio is currently 29.26%.

Elevance Health Company Profile

Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.

Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.

Want to see what other hedge funds are holding ELV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.